Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction

Dr. Warrick Bishop is a practicing cardiologist and author dedicated to patient education about heart health. In this episode, Dr. Bishop discusses dilated cardiomyopathy—an enlarged heart with poorly functioning muscle—and importantly, what patients should do if their condition improves. He explores the causes, treatments, prognosis, and recent research findings that challenge common assumptions about medication management.

Key Takeaways:

• Dilated cardiomyopathy is defined as an enlarged heart with dysfunctional muscle, primarily measured by ejection fraction (the percentage of blood pumped with each heartbeat).

• A normal ejection fraction is approximately 60%; less than 40% indicates cardiomyopathy, with worse disease showing progressively lower ejection fractions.

• Common causes include infections, alcohol abuse, certain chemotherapy drugs, prolonged elevated heart rates, genetic factors, and idiopathic (unknown) origins.

• Treatment involves medications that reduce blood pressure and workload on the heart, regulate heart rate, and modulate hormonal influences, including beta blockers and newer agents like Secubitril/Valsartan combinations.

• Prognosis has improved significantly—more than 50-60% of patients now show recovery compared to the historical "one-third rule," with improvement typically visible within three to six months.

• The TREND-HF study demonstrated that nearly 40% of patients relapsed when medications were withdrawn after heart function improved, proving long-term medication adherence is essential.

• Even when the heart recovers to near-normal function, patients should remain on medications indefinitely rather than discontinuing therapy.